Efficacy and safety of nebivolol in Korean patients with hypertension by age and sex: a subanalysis from the BENEFIT-KOREA study

• Главные авторы: Kyoung Im Cho (Автор), Dong Woon Jeon (Автор), Hyo Seung Ahn (Автор), Dong Kyu Jin (Автор), Hyun Sang Lee (Автор), Jong-Young Lee (Автор), Hong-Seok Lim (Автор), Athanasios J. Manolis (Автор), Seung-Woon Rha (Автор), Sang Won Park (Автор)
• Формат: ‌
• Опубликовано: BMC, 2021-03-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Abstract Background BENEFIT-KOREA (BEnefits after 24 weeks of NEbivolol administration For essential hypertensIon patients wiTh various comorbidities and treatment environments in Korea) study, an observational study in South Korea, demonstrated the efficacy and safety of nebivolol in Asian patients...